Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Stanford University
University of California, Davis
Hoffmann-La Roche
ViroMissile, Inc.
University of Florida
University of Nebraska
Guerbet
Fusion Pharmaceuticals Inc.
Eli Lilly and Company
Tanabe Pharma America, Inc.
Eli Lilly and Company
Travera Inc
Jonsson Comprehensive Cancer Center
MedSIR
University Health Network, Toronto
Novartis
Eli Lilly and Company
Aminex Therapeutics, Inc.
Travera Inc
Rigshospitalet, Denmark
Novartis
Georgetown University
Ohio State University Comprehensive Cancer Center
Xencor, Inc.
Provectus Pharmaceuticals
SpeciCare
Novartis
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
SWOG Cancer Research Network
University of Southern California
Stanford University
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Rutgers, The State University of New Jersey